Olopatadine Overview Categories 21 Ophthalmological preparations21.6 Non-specific anticonjunctivitis preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Olopatadine Manufacturers of Olopatadine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Olopatadine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 2.22 to 0 mg/ml1.1 (1.11)24 hourlyopthalmicThe dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. Paedriatic Dosage (20kg) 2.22 to 0 mg/ml1.1 (1.11)24 hourlyopthalmicThe dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 ho Neonatal Dosage (3kg) 2.22 to 0 mg/ml1.1 (1.11)24 hourlyopthalmicThe dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Back to top Manufacturers of Olopatadine in Pakistan Atco Barrett Elko Festel Helix Hygeia Innvotek Medipak Remington Sante Shaigan Vega Back to top Previous Drug Generic - Next Drug Generic
Olopatadine Overview Categories 21 Ophthalmological preparations21.6 Non-specific anticonjunctivitis preparations Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Olopatadine Manufacturers of Olopatadine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Olopatadine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 2.22 to 0 mg/ml1.1 (1.11)24 hourlyopthalmicThe dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. Paedriatic Dosage (20kg) 2.22 to 0 mg/ml1.1 (1.11)24 hourlyopthalmicThe dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 ho Neonatal Dosage (3kg) 2.22 to 0 mg/ml1.1 (1.11)24 hourlyopthalmicThe dose is one drop of olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Back to top Manufacturers of Olopatadine in Pakistan Atco Barrett Elko Festel Helix Hygeia Innvotek Medipak Remington Sante Shaigan Vega Back to top Previous Drug Generic - Next Drug Generic